Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR2K2 Inhibitors

OR2K2 inhibitors are a class of chemical compounds designed to specifically target the OR2K2 receptor, a member of the olfactory receptor family within the G-protein-coupled receptor (GPCR) superfamily. While olfactory receptors like OR2K2 are primarily associated with the detection of odorants in the nasal epithelium, their expression in various non-olfactory tissues suggests that they may have broader biological roles. OR2K2 inhibitors function by binding to the receptor, thereby blocking or modulating its interaction with natural ligands. This inhibition can alter the signaling pathways that OR2K2 regulates, leading to changes in various physiological processes. Research into OR2K2 inhibitors is focused on elucidating the receptor's role beyond olfaction, particularly in systems where its function is not yet fully understood. The chemical nature of OR2K2 inhibitors is diverse, with different compounds exhibiting varying degrees of specificity, potency, and mechanisms of action. Some of these inhibitors may act as competitive antagonists, binding directly to the active site of OR2K2 and preventing natural ligands from activating the receptor. This mode of action effectively blocks the receptor's signaling capabilities. Other inhibitors may function allosterically, binding to a different site on the receptor and inducing conformational changes that reduce or alter its activity. The development of OR2K2 inhibitors often relies on advanced structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and molecular modeling, to identify critical binding sites on the receptor and optimize the interactions between the inhibitor and OR2K2. Researchers aim to create inhibitors that are highly selective for OR2K2, ensuring that they specifically target this receptor without affecting other GPCRs or unrelated proteins. By studying these inhibitors, scientists can gain a deeper understanding of the functional roles of OR2K2 in various biological systems and how modulating its activity can influence specific cellular processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Inhibitor of protein transport that can disrupt GPCR trafficking to the membrane, impacting OR2K2 expression.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

Inhibits Gi/o type G-proteins, which can affect downstream signaling of GPCRs including OR2K2.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Directly activates adenylyl cyclase, increasing cAMP and potentially affecting GPCR signaling cascades involving OR2K2.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$97.00
$144.00
$648.00
47
(2)

PKA inhibitor that can alter cAMP-mediated signaling pathways, possibly impacting OR2K2 function.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

Protein kinase C inhibitor that can affect GPCR-mediated signaling, potentially impacting OR2K2 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor that can disrupt downstream signaling of GPCRs, potentially affecting OR2K2.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

Inhibits myosin light-chain kinase, which can influence GPCR-related cytoskeletal changes affecting OR2K2 signaling.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

ROCK inhibitor which can influence GPCR signal transduction, potentially affecting OR2K2.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor that can disrupt GPCR-mediated signaling pathways, potentially affecting OR2K2.